HOTH — Hoth Therapeutics Balance Sheet
0.000.00%
- $18.56m
- $9.55m
- 32
- 25
- 58
- 31
Annual balance sheet for Hoth Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 4.69 | 10.4 | 6.64 | 9.29 | 7.04 |
| Net Total Receivables | — | 0.05 | 0 | — | — |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 4.78 | 10.6 | 6.73 | 9.43 | 7.64 |
| Net Property, Plant And Equipment | 0 | — | — | 0.055 | 0.031 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 5.24 | 11 | 6.76 | 9.52 | 7.71 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 0.312 | 0.868 | 1.39 | 0.679 | 0.831 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.597 | 1.1 | 1.64 | 0.705 | 0.834 |
| Redeemable Preferred Stock | |||||
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 4.65 | 9.88 | 5.12 | 8.82 | 6.88 |
| Total Liabilities & Shareholders' Equity | 5.24 | 11 | 6.76 | 9.52 | 7.71 |
| Total Common Shares Outstanding |